Imperial College Healthcare NHS Trust in London, UK, has chosen RayStation as the sole treatment planning system for two sites in London: Charing Cross Hospital and Hammersmith Hospital. RayStation was selected as the best solution following a thorough evaluation of all potential treatment planning systems on the market.
The Imperial College Healthcare NHS Trust operates five hospitals in London, plus a range of community health services. Its radiation therapy services are provided at Charing Cross Hospital and Hammersmith Hospital. RayStation will replace two different treatment planning systems currently in use at the hospitals.
The two hospitals will use RayStation for all radiation therapy treatment planning activities, as well as all pre-treatment virtual simulation. RayStation will replace the hospitals’ current standalone system for virtual simulation. The purchase comprises a broad range of functionality, including 3D-CRT, IMRT, VMAT, multi-criteria optimization, automated breast planning and adaptive planning.
Johan Löf, CEO of RaySearch, says: “We are very pleased to support the needs of these two leading London hospitals. The aim with RayStation is to provide the most comprehensive functionality. This makes it possible for clinics to consolidate multiple systems, increase efficiency and reduce the need for staff training. We look forward to a successful partnership.”
About Imperial College Healthcare NHS Trust
Imperial College Healthcare NHS Trust provides acute and specialist healthcare for a population of nearly two million people in north west London, and more beyond. The Trust has five hospitals in London – Charing Cross, Hammersmith, Queen Charlotte’s & Chelsea, St Mary’s and The Western Eye – and runs a growing number of community services. With its academic partner, Imperial College London, the trust is one of the UK’s 11 academic health science centres, working to ensure the rapid translation of research for better patient care and excellence in education.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy*. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company recently launched the next-generation oncology information system, RayCare*, which comprises a new product area for RaySearch. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.
To learn more about RaySearch, go to: www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00